CVS (NYSE:CVS) and Aetna (NYSE:AET) will merge into one company, and the coming synergies as the companies integrate could provide big benefits to Medicaid and Medicare users.
During the press conference discussing the merger, company executives said the combined company would “help consumers navigate the Medicare and Medicaid confusion.”
While at the same time, Medicare and Medicaid will provide an opportunity for the combined company, CVS CEO Larry Merlo noted that “the real opportunity is in government businesses: Medicare and Medicaid,” noting, that as a combined company, they will be able to better coordinate care and eliminate waste and unnecessary spending, which will mean lower costs and better care, improving these plans for customers.
Critics of both Medicare and Medicaid say the plans offer a limited choice of doctors for patients, pricing problems and gaps in coverage.
CVS will purchase Aetna with a combination of both outstanding shares and stock. The transaction values Aetna at approximately $207 per share or approximately $69 billion. Including Aetna’s debt, the total value of the transaction is $77 billion.
In their press release discussing the deal, CVS said “This transaction fills an unmet need in the current health care system and presents a unique opportunity to redefine access to high-quality care in lower cost, local settings—whether in the community, at home, or through digital tools.”
The company expects the transaction to close in the second half of 2018, pending regulatory approval.